Caliway secures FDA clearance for CBL-514 clinical trial
Caliway intends to commence both pivotal Phase III trials soon, with clinical results for CBL-0301 and CBL-0302 expected in 2027.
Analysis
View MoreAPIs to the rescue?
Oral bioavailability remains one of the biggest challenges in drug development, particularly for small-molecule APIs with poor solubility or permeability. Liam Critchley explores how pharmaceutical companies are using integrated formulation...
AI now: What QbD and PAT missed
Cool heads, smart chains
Sustainability vs suitability
Integrating sustainability compliance